North America Ophthalmic Photocoagulator Market Databank
The Ophthalmic Photocoagulator market was valued at $150.2 Million in 2020, and is projected to reach $251.5 Million by 2029 growing at a CAGR of 5.94% from 2021 to 2029. Hospitals segment is expected to be the highest contributor to this market, with $64.9 Million in 2020, and is anticipated to reach $108.4 Million by 2029, registering a CAGR of 5.91%. Ambulatory Surgery Centers segment is anticipated to reach $82.2 Million by 2029 with the highest CAGR of 5.97%. Hospitals and Ambulatory Surgery Centers segments collectively expected to account for about 75.8% share of the Ophthalmic Photocoagulator market in 2020, with the former constituting around 43.2% share. Ambulatory Surgery Centers and Ophthalmology Clinics segments are expected to witness significant growth rates at a CAGR of 5.97% and 5.96% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 56.8% in the overall Ophthalmic Photocoagulator market in 2020, and is anticipated to reach 56.9% by 2029.
- 1. GLOBAL OPHTHALMIC PHOTOCOAGULATOR MARKET, BY END USE
- 1.1. OVERVIEW
- 1.2. HOSPITALS
- 1.2.1 HOSPITALS MARKET, BY REGION
- 1.2.1.1 North America Hospitals Market, By Country
- 1.2.1.2 Europe Hospitals Market, By Country
- 1.2.1.3 Asia-Pacific Hospitals Market, By Country
- 1.2.1.4 Rest of World Hospitals Market, By Country
- 1.3. AMBULATORY SURGERY CENTERS
- 1.3.1 AMBULATORY SURGERY CENTERS MARKET, BY REGION
- 1.3.1.1 North America Ambulatory Surgery Centers Market, By Country
- 1.3.1.2 Europe Ambulatory Surgery Centers Market, By Country
- 1.3.1.3 Asia-Pacific Ambulatory Surgery Centers Market, By Country
- 1.3.1.4 Rest of World Ambulatory Surgery Centers Market, By Country
- 1.4. OPHTHALMOLOGY CLINICS
- 1.4.1 OPHTHALMOLOGY CLINICS MARKET, BY REGION
- 1.4.1.1 North America Ophthalmology Clinics Market, By Country
- 1.4.1.2 Europe Ophthalmology Clinics Market, By Country
- 1.4.1.3 Asia-Pacific Ophthalmology Clinics Market, By Country
- 1.4.1.4 Rest of World Ophthalmology Clinics Market, By Country
- 2. GLOBAL OPHTHALMIC PHOTOCOAGULATOR MARKET, BY APPLICATION
- 2.1. OVERVIEW
- 2.2. GLAUCOMA
- 2.2.1 GLAUCOMA MARKET, BY REGION
- 2.2.1.1 North America Glaucoma Market, By Country
- 2.2.1.2 Europe Glaucoma Market, By Country
- 2.2.1.3 Asia-Pacific Glaucoma Market, By Country
- 2.2.1.4 Rest of World Glaucoma Market, By Country
- 2.3. DIABETIC RETINOPATHY
- 2.3.1 DIABETIC RETINOPATHY MARKET, BY REGION
- 2.3.1.1 North America Diabetic Retinopathy Market, By Country
- 2.3.1.2 Europe Diabetic Retinopathy Market, By Country
- 2.3.1.3 Asia-Pacific Diabetic Retinopathy Market, By Country
- 2.3.1.4 Rest of World Diabetic Retinopathy Market, By Country
- 2.4. AGE-RELATED MACULAR DEGENERATION
- 2.4.1 AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION
- 2.4.1.1 North America Age-related Macular Degeneration Market, By Country
- 2.4.1.2 Europe Age-related Macular Degeneration Market, By Country
- 2.4.1.3 Asia-Pacific Age-related Macular Degeneration Market, By Country
- 2.4.1.4 Rest of World Age-related Macular Degeneration Market, By Country
- 2.5. MACULAR EDEMA
- 2.5.1 MACULAR EDEMA MARKET, BY REGION
- 2.5.1.1 North America Macular Edema Market, By Country
- 2.5.1.2 Europe Macular Edema Market, By Country
- 2.5.1.3 Asia-Pacific Macular Edema Market, By Country
- 2.5.1.4 Rest of World Macular Edema Market, By Country
- 2.6. OTHER APPLICATIONS
- 2.6.1 OTHER APPLICATIONS MARKET, BY REGION
- 2.6.1.1 North America Other Applications Market, By Country
- 2.6.1.2 Europe Other Applications Market, By Country
- 2.6.1.3 Asia-Pacific Other Applications Market, By Country
- 2.6.1.4 Rest of World Other Applications Market, By Country
- 3. GLOBAL OPHTHALMIC PHOTOCOAGULATOR MARKET, BY REGION
- 3.1. OVERVIEW
- 3.2. NORTH AMERICA
- 3.2.1 NORTH AMERICA OPHTHALMIC PHOTOCOAGULATOR MARKET, BY END USE
- 3.2.2 NORTH AMERICA OPHTHALMIC PHOTOCOAGULATOR MARKET, BY APPLICATION
- 3.2.3 NORTH AMERICA OPHTHALMIC PHOTOCOAGULATOR MARKET, BY COUNTRY
- 3.2.3.1 U.S.
- 3.2.3.1.1 U.S. Ophthalmic Photocoagulator Market, By End use
- 3.2.3.1.2 U.S. Ophthalmic Photocoagulator Market, By Application
- 3.2.3.2 Canada
- 3.2.3.2.1 Canada Ophthalmic Photocoagulator Market, By End use
- 3.2.3.2.2 Canada Ophthalmic Photocoagulator Market, By Application
- 3.2.3.3 Mexico
- 3.2.3.3.1 Mexico Ophthalmic Photocoagulator Market, By End use
- 3.2.3.3.2 Mexico Ophthalmic Photocoagulator Market, By Application
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook